Literature DB >> 16624328

Exhaustion of the Frank-Starling mechanism in conscious dogs with heart failure induced by chronic coronary microembolization.

Robert M Gill1, Bonita D Jones, Angela K Corbly, Dan G Ohad, Gerald D Smith, George E Sandusky, Michael E Christe, Jie Wang, Weiqun Shen.   

Abstract

The role of the Frank-Starling mechanism in the regulation of cardiac systolic function in the ischemic failing heart was examined in conscious dogs. Left ventricular (LV) dimension, pressure and systolic function were assessed using surgically implanted instrumentations and non-invasive echocardiogram. Heart failure was induced by daily intra-coronary injections of microspheres for 3-4 weeks via implanted coronary catheters. Chronic coronary embolization resulted in a progressive dilation of the left ventricle (12+/-3%), increase in LV end-diastolic pressure (118+/-19%), depression of LV dP/dt(max) (-19+/-4%), fractional shortening (-36+/-7%), and cardiac work (-60+/-9%), and development of heart failure, while the LV contractile response to dobutamine was depressed. A brief inferior vena caval occlusion in dogs with heart failure decreased LV preload to match the levels attained in their control state and caused a further reduction of LV dP/dt(max), fractional shortening, stroke work and cardiac work. Moreover, in response to acute volume loading, the change in the LV end-diastolic dimension-pressure (DeltaLVEDD-DeltaLVEDP) curve in the failing heart became steeper and shifted significantly to the left, while the increases in LV stroke work and cardiac work were blunted. Thus, our results suggest that the Frank-Starling mechanism is exhausted in heart failure and unable to further respond to increasing volume while it plays an important compensatory role in adaptation to LV dysfunction in heart failure.

Entities:  

Mesh:

Year:  2006        PMID: 16624328     DOI: 10.1016/j.lfs.2006.01.045

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

Review 1.  In vivo assessment of regional mechanics post-myocardial infarction: A focus on the road ahead.

Authors:  Eva Romito; Tarek Shazly; Francis G Spinale
Journal:  J Appl Physiol (1985)       Date:  2017-02-23

2.  GSK-3β Localizes to the Cardiac Z-Disc to Maintain Length Dependent Activation.

Authors:  Marisa J Stachowski-Doll; Maria Papadaki; Thomas G Martin; Weikang Ma; Henry M Gong; Stephanie Shao; Shi Shen; Nitha Aima Muntu; Mohit Kumar; Edith Perez; Jody L Martin; Christine S Moravec; Sakthivel Sadayappan; Stuart G Campbell; Thomas Irving; Jonathan A Kirk
Journal:  Circ Res       Date:  2022-02-16       Impact factor: 23.213

3.  Catheter-based intervention for symptomatic patient with severe mitral regurgitation and very poor left ventricular systolic function - Safe but no room for complacency.

Authors:  Poay Huan Loh; Christos V Bourantas; Pak Hei Chan; Nikolaj Ihlemann; Fin Gustafsson; Andrew L Clark; Susanna Price; Carlo Di Mario; Neil Moat; Farqad Alamgir; Rodrigo Estevez-Loureiro; Lars Søndergaard; Olaf Franzen
Journal:  World J Cardiol       Date:  2015-11-26

4.  Diaphragmatic dysfunction associates with dyspnoea, fatigue, and hiccup in haemodialysis patients: a cross-sectional study.

Authors:  Bin Wang; Qing Yin; Ying-Yan Wang; Yan Tu; Yuchen Han; Min Gao; Mingming Pan; Yan Yang; Yufang Xue; Li Zhang; Liuping Zhang; Hong Liu; Rining Tang; Xiaoliang Zhang; Jingjie Xiao; Xiaonan H Wang; Bi-Cheng Liu
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

5.  Effects of intravenous diltiazem in a rat model of experimental coronary thrombotic microembolism.

Authors:  Yupeng Bai; Liqun Hu; Jie Wu; Ye Gu; Lun Li; Bo Gao; Hong Jiang
Journal:  Exp Ther Med       Date:  2013-08-16       Impact factor: 2.447

Review 6.  Renal function monitoring in heart failure - what is the optimal frequency? A narrative review.

Authors:  Ahmed Al-Naher; David Wright; Mark Alexander John Devonald; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2017-10-22       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.